Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women

MLA

Fischer, Nicole M., et al. “Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.” The Journal of Clinical Endocrinology & Metabolism, vol. 106, no. 2, Feb. 2021, pp. e650–59. EBSCOhost, https://doi.org/10.1210/clinem/dgaa718.

APA

Fischer, N. M., Nieuwenhuis, T. O., Singh, B., Yenokyan, G., & Segars, J. H. (2021). Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women. The Journal of Clinical Endocrinology & Metabolism, 106(2), e650–e659. https://doi.org/10.1210/clinem/dgaa718

Chicago

Fischer, Nicole M, Tim O Nieuwenhuis, Bhuchitra Singh, Gayane Yenokyan, and James H Segars. 2021. “Angiotensin-Converting Enzyme Inhibitors Reduce Uterine Fibroid Incidence in Hypertensive Women.” The Journal of Clinical Endocrinology & Metabolism 106 (2): e650–59. doi:10.1210/clinem/dgaa718.